Biogenic Synthesis of Silver Nanoparticles, Characterization and Their Applications—A Review

With the growing awareness for the need of sustainable environment, the importance of synthesizing and the application of green nanoparticles has gained special focus. Among various metal nanoparticles, silver nanoparticles (AgNPs) have gain significant attention. AgNPs are synthesized conventionally by physical and chemical methods using chemicals such as reducing agents, which are hazardous to environment due to their toxic properties, provoking a serious concern to create and develop environment friendly methods. Thus, biological alternatives are emerging to fill gaps, such as green syntheses that use biological molecules taken from plant sources in the form of extracts, which have shown to be superior to chemical and physical approaches. These biological molecules derived from plants are assembled in a highly regulated manner to make them suitable for metal nanoparticle synthesis. The current review outlines the wide plant diversity that may be used to prepare a rapid and single-step procedure with a green path over the traditional ones, as well as their antifungal activity.

Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based Approach

Poor water solubility of new chemical entities is considered as one of the main obstacles in drug development, as it usually leads to low bioavailability after administration. To overcome these problems, the selection of the appropriate formulation technology needs to be based on the physicochemical properties of the drug and introduced in the early stages of drug research. One example of the new potential drug substance with poor solubility is DK-I-60-3, deuterated pyrazoloquinolinone, designed for the treatment of various neuropsychiatric disorders. In this research, based on preformulation studies, nanocrystal technology was chosen to improve the oral bioavailability of DK-I-60-3. Nanocrystal dispersions stabilized by sodium lauryl sulfate and polyvinylpyrrolidone were prepared by modified wet media milling technique, with the selection of appropriate process and formulation parameters. The nanoparticles characterization included particle size and zeta potential measurements, differential scanning calorimetry, X-ray powder diffraction, dissolution and solubility study, and in vivo pharmacokinetic experiments. Developed formulations had small uniform particle sizes and were stable for three months. Nanonization caused decreased crystallite size and induced crystal defects formation, as well as a DK-I-60-3 solubility increase. Furthermore, after oral administration of the developed formulations in rats, two to three-fold bioavailability enhancement was observed in plasma and investigated organs, including the brain.